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AbstrACt
Introduction Although international guidelines 
recommend self-care as an integral part of routine heart 
failure management, and despite evidence supporting 
the positive outcomes related to self-care, patients are 
frequently unable to adhere. Self-care can be modified 
through behaviour change interventions (BCIs). However, 
previous self-care interventions have shown limited 
success in improving adherence to self-care, because 
they were neither theory-based nor well defined, 
which precludes the identification of underlying causal 
mechanisms as well as reproducibility of the intervention. 
Thus, our aim is to develop an intervention manual 
that contains theory-based BCIs that are well-defined 
using eight descriptors proposed to describe BCIs in a 
standardised way.
Methods and analysis BCIs will be based on statements 
of findings derived through qualitative meta-summary 
techniques and a quantitative meta-analysis. These 
reviews will be used to extract factors (target behaviours) 
associated with self-care adherence/non-adherence. 
Extracted target behaviours will be mapped onto the 
‘Capability, Opportunity, Motivation and Behaviour’ 
(COM-B) model to capture the underlying mechanisms 
involved. To develop approaches for change, the 
‘Taxonomy of Behaviour Change Techniques’ will be used 
to allow effective mapping of the target behaviours onto 
established behaviour change techniques. Suggested 
BCIs will then be translated into locally relevant 
interventions using the Normalisation Process Theory to 
overcome the difficulties of implementing theoretically 
derived interventions into practice. Finally, a consensus 
development method will be employed to fine-tune the 
content and acceptability of the intervention manual 
to increase the likelihood of successfully piloting and 
implementing future BCIs into the German healthcare 
system.
Ethics and dissemination This study has been 
reviewed and approved by the Ethics Committee of 
the Medical Faculty of the Heinrich Heine University 
Düsseldorf, Germany (Ref #: 2018-30). The results will 
be disseminated via peer-reviewed journal publications, 
conference presentations and stakeholder engagement 
activities.
trial registration number DRKS00014855; Pre-results.
IntroduCtIon
Heart failure (HF) is a major clinical and public 
health problem worldwide associated with 
significant healthcare expenditure, morbidity 
and mortality.1 In Germany, the prevalence 
of HF is estimated at 3%–4% among adults 
and increases steeply with age.1Heart failure 
is the most common cause of hospital admis-
sions of patients and ranks third as cause of 
death.1 Treatment costs are strongly driven 
by expenditure for repeated hospitalisations 
and increase with disease progression.2 Thus, 
HF represents a growing public health and 
health economic issue as the population ages. 
On an individual level, patients with HF expe-
rience physical and psychological distress 
such as fatigue, dyspnoea, pain, depression 
or problems regarding concentration, all of 
strengths and limitations of this study
 ► Behaviour change intervention  (BCI) is based on 
sound theoretical framework.
 ► Extensive consultation with potential key stakehold-
ers, that is, end users and healthcare providers, will 
inform intervention development.
 ► Final intervention manual will contain specific in-
formation regarding eight descriptors suggested 
for the standardised description of BCIs to allow for 
replication.
 ► Full randomised controlled trial (RCT) design not 
possible within the study budget and time  frame, 
but study will collect important data to inform a full-
scale RCT in the future.
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which are having a major negative impact on the person’s 
quality of life.3 
After being diagnosed with HF, the prognosis depends 
on two major components: one is physician-based and 
encompasses all aspects of appropriate treatment, moni-
toring of effects and communicating relevant infor-
mation; the other is patient-based and refers to the 
concept of self-care including the motivation to adhere 
to diagnostic and therapeutic recommendations. HF 
care should be exerted in a multidisciplinary team and 
involves a patient-centred approach seeking to system-
atically develop emotional, physical, intellectual and 
social resources of the patient.4 Ultimately, such strategy 
is thought to empower patients in order to improve and 
sustain efficacious self-care behaviour. The term self-care 
refers to
the individual’s ability to manage the symptoms, treat-
ment, physical and psychosocial consequences and 
life style changes inherent in living with a chronic 
condition. Efficacious self-care encompasses the abil-
ity to monitor one’s condition and to effect the cogni-
tive, behavioural and emotional responses necessary 
to maintain a satisfactory quality of life.5 (p. 178)
Since 2008, the European Guidelines for Diagnosis and 
Treatment of HF strongly emphasise self-care (Grade IA 
recommendation) as part of routine HF management 
and patient empowerment.4 6
Generally, self-care mandates a sustained effort in order 
to impact on any chronic disease. In particular, successful 
HF therapy requires a substantial amount of self-care and 
adherence to multiple aspects of the treatment regimen.7 
For example, HF self-care encompasses a complex set of 
behaviours including daily weighing, low-sodium diet, 
fluid restriction, regular physical exercise, medication 
taking, symptom monitoring involving exercising and 
developing an awareness of exacerbating symptoms such 
as shortness of breath, lower extremity oedema, fatigue or 
activity intolerance.8 Hence, such adherence to HF self-
care is considered key in order to achieve a positive effect 
on disease progression. Adherence is defined as the extent 
to which a patient’s behaviour coincides with the recom-
mendations made by healthcare providers.9 The concept 
of adherence focuses on specific patient behaviours 
emphasising the need for agreement between patient 
and healthcare provider. Sound evidence from system-
atic reviews has shown that adherence to self-care signifi-
cantly reduces HF-related hospitalisations,10 morbidity 
and mortality,11 decreases hospital readmissions12 and 
improves HF-related quality of life.13 Conversely, failure 
to adhere to recommended self-care is associated with HF 
exacerbation,14 frequent hospital readmissions and low 
survival.15
Patients with HF are faced with the difficulty of 
adopting complex recommendations including adher-
ence to multiple aspects of the treatment regimen and 
lifestyle adjustments in order to prevent disease progres-
sion. Self-management interventions aiming at improving 
self-care generally seek to empower individuals by 
endowing them with the skills necessary to actively partic-
ipate in the management of their chronic condition.5 
Several systematic reviews investigating the efficacy and 
effectiveness of self-management interventions involving 
home and/or clinic visits, education sessions (eg, ‘giving 
information’), telemonitoring approaches and follow-up 
telephone calls for patients with HF have been published 
to date showing inconsistent results. Earlier conducted 
systematic reviews had suggested a relevant benefit in rela-
tion to hard clinical endpoints including all-cause hospi-
talisation and HF-related hospitalisations.12 16 Despite 
favourable pooled effects, some more recently conducted 
large randomised controlled trials (RCTs) including 
multisite studies showed inconsistent results.17–20 Thus, 
the effectiveness of self-management interventions in 
terms of all-cause hospitalisation, HF-related hospitalisa-
tions and death remains inconclusive until today. Part of 
this heterogeneity may be attributable to the absence of 
self-management interventions applying behaviour strate-
gies and/or cognitive behavioural strategies (rather than 
simply educational interventions), insufficient use of 
theoretical models underpinning the intervention or lack 
of detailed description of the active ingredient(s) driving 
the intervention.
In more detail, evidence of grade A (high quality) 
exists that interventions using established, well-defined 
behaviour change techniques (ie, the ‘active ingredient’ 
of an intervention) are most effective.21 Yet, a review of 
self-management interventions promoting self-care of 
patients with HF came to the conclusion that only very 
few studies used explicit theory-based interventions, while 
the majority still lacked specificity of the mechanisms 
employed to improve self-care.22 Such critique was also 
articulated by Michie and colleagues,23 who stated that 
interventions are commonly designed without applying 
an evidence-based underlying model. Instead, interven-
tions are frequently based on implicit common sense 
models.24 Similarly, a most recent critical reflection on 
methodological challenges encountered in meta-analyses 
on self-care interventions advised intervention designers 
to pay particular attention to the causal mechanisms 
underlying the intervention when designing studies.25 
Hence, absent effects of previous self-management inter-
ventions seeking to improve self-care may very well be 
attributable to the lack of theoretical underpinning or 
the use of ill-chosen strategies.26 27
Another criticism relates to the lack of detailed descrip-
tion of the active ingredient(s) driving a successful 
intervention. Detailed descriptions are of paramount 
importance for replication, allowing scientists to accu-
mulate evidence about intervention effects and causal 
mechanisms.28 For the results to be judged, reproduc-
ible, sufficiently detailed information must be provided 
to allow the potential for reproducing the same or similar 
results.29 Yet, specific features rendering interventions 
successful are often ill-defined in research publications, 
which limit reproducibility.18 Hence, a systematic method 
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that incorporates a thorough understanding of the nature 
of the behaviour to be changed (ie, the target behaviour), 
an appropriate system for characterising interventions 
and their components as well as descriptors suggested for 
the standardisation of reporting behaviour change inter-
ventions (BCIs) are mandatory. In this way, a ‘science of 
change’ can be established in which effective interven-
tions can be understood and replicated.30
In summary, it can be stated that inconclusive results of 
existing self-management interventions for patients with 
HF may very well be attributable to the absence of inter-
ventions applying behaviour strategies and/or cognitive 
behavioural strategies, insufficient use of theoretical 
models underpinning the intervention or lack of detailed 
description of the active ingredient(s) driving the inter-
vention, thus emphasising the need to design an interven-
tion that allows for these likely sources of heterogeneity. 
Therefore, the aim of this study is to develop well-defined 
theory-based BCIs based on an underlying behaviour 
model that allows for identifying effective behaviour 
change techniques.
MEthods And AnAlysIs
Patient and public involvement
Our research question emerged from the findings of 
published literature on self-management interventions as 
described above. Patients and the public are involved in 
this early stage of designing BCIs through their involve-
ment as members of the participatory planning group. 
To facilitate successful completion of each stage of the 
proposed work programme as described below, a partic-
ipatory planning group will be established right at the 
beginning of the study. Intervention development and 
implementation should be based on meaningful partic-
ipation of key stakeholders.31 Thus, for the life of this 
project, a participatory planning group will be deployed 
to assist in the development of an intervention manual 
containing well-defined theory-based BCIs. The plan-
ning group will be composed of key stakeholders who 
have a particular interest in designing BCIs including 
intervention developers, intervention implementers and 
intervention end users (ie, patients with HF). For identi-
fying key stakeholders, we will be using the guiding ques-
tions proposed by Preskill and Jones.32 They consider 
the following five domains to be relevant for the selec-
tion process: (1) expertise, (2) diverse perspectives, 
(3) responsibility and authority, (4) influence and (5) 
commitment. The participatory planning group will meet 
at least every 6 months or at shorter intervals, if required.
using the MrC framework for designing complex 
interventions
The Medical Research Council (MRC) four-stage frame-
work consisting of ‘develop-test-evaluate-implement’ will 
be used as an underlying framework for researching 
complex interventions. Before embarking on a full RCT, 
preparatory and exploratory studies may be required to 
gradually refine the study design.33 To develop an accept-
able, effective and sustainable complex intervention, key 
elements are proposed.34 The present project proposal 
addresses the ‘development’ stage of the MRC framework 
to design an intervention on a theoretical base prior to 
its preliminary testing in an exploratory trial (figure 1).
Essentially, in the development stage, a paper-based 
exercise will be undertaken dealing with issues such as: 
the specific content of the intervention, who will deliver 
it, how long it will take to deliver, what each stakeholder 
will actually do as part of the intervention, and should the 
intervention prove effective,  how it may be implemented 
into routine practice to increase the likelihood of its 
adoption by patients and health services. Providing robust 
answers to the above questions is of paramount impor-
tance to avoid what Chalmers and Glasziou35 referred to as 
‘research waste’, that is, research where insufficient effort 
has been made to develop and pilot test the interven-
tion before proceeding to a full RCT. However, since the 
MRC framework provides no specific guidance on how to 
link theory and intervention techniques, the Capability, 
Opportunity, Motivation  (COM-B) model of behaviour23 
in combination with the Taxonomy of Behaviour Change 
Techniques36 will be employed. To our knowledge, 
COM-B is the only model that provides a systematic and 
transparent way of identifying target behaviours and tech-
niques judged to be most effective in changing behaviour. 
The COM-B model has been applied successfully in inter-
vention development in various health-related contexts 
including changing eating behaviours,37 enhancing medi-
cation adherence,38 reducing blood pressure-related 
disease burden39 or improving hearing aid use in adults.40 
To manage the process of developing BCIs in a system-
atic fashion, our work programme is guided by four stages 
following intervention mapping.41
Stage 1: systematic reviews for extracting desirable/undesirable 
behaviours
Based on the findings from our recently completed system-
atic review and qualitative meta-summary,42 37 statements 
of findings pertaining to self-care were identified repre-
senting a comprehensive inventory of findings across 31 
qualitative (QUAL) reports. However, the evidence from 
qualitative enquiries alone might not be satisfactory for 
designing sound evidence-based interventions. Thus, 
in addition to drawing on our qualitative synthesis we 
have identified a comprehensive systematic review and 
meta-analysis (QUAN) based on 65 reports describing the 
current evidence concerning determinants of self-care in 
patients with HF.43 Hence, two up-to-date comprehensive 
reviews synthesising qualitative and quantitative studies 
will be used to first identify and then extract all factors 
(target behaviours) associated with self-care adherence/
non-adherence. Two members of staff will identify and 
extract all behaviours associated with adherence/non-ad-
herence to HF self-care independently from each other 
and then compare notes to create a final list of common 
behaviours from both reviews (QUAN+QUAL). At the 
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end of stage 1, a final list of common factors extracted is 
produced in order to map them onto the COM-B model 
of behaviour (see stage 2 below).
Stage 2: mapping of extracted behaviours onto the COM-B 
behaviour model
The application of underlying behavioural theories is vital 
for designing BCIs,44 because theory-driven interventions 
are considered superior.45 Because of its successful utilisa-
tion in intervention development, the COM-B model will 
be used as a universal behavioural theory to enhance the 
understanding of causal mechanisms underlying behaviour 
change (figure 2). The COM-B model will allow a more 
fine-grained analysis of the causes of adherence/non-adher-
ence, so that an intervention can be selected more precisely 
to target a particular behaviour. The COM-B model in 
combination with the ‘Behaviour Change Wheel’23 is the 
centrepiece of designing BCIs. The behaviour change 
wheel—consisting of three concentric circles—will aid 
in visualising how intrapersonal and/or interpersonal 
behaviour can be changed by targeting specific underlying 
modifiable mechanisms (figure 3). Thus, each of the factors 
identified in stage 1 will be mapped onto the COM-B model 
(equals inner circle of the wheel) using the definitions 
regarding components and subcomponents as described 
below. If there are difficulties in classifying the factors onto 
the COM-B model, a second opinion will be obtained until 
a clear assignment can be made. We are aware that not 
all factors identified from the literature review will fit into 
exactly one subcomponent since the effects of the factors 
might work via a number of components.38 This, however, 
should not be considered as a limitation of the model 
because the effects of the factors are explained by compo-
nents within the model. For quality assurance, all factors 
mapped onto the COM-B model will be double-checked for 
accuracy by a research team member not involved in the 
mapping exercise.
The COM-B model assists in understanding behaviour 
and as such will provide an explanation for why patients 
with HF adhere and/or non-adhere to self-care. The 
COM-B model consists of three components: (1) capa-
bility, (2) opportunity and (3) motivation (COM) that 
causes the performance of behaviour (B) and in turn 
influences these three components.
To capture important distinctions, the three compo-
nents are further divided into two subcomponents 
each. ‘Capability’ is subdivided into psychological capa-
bility (the capacity to engage in the necessary thought 
processes) and physical capability (the capacity to engage 
in necessary physical processes).23 Psychological capa-
bility includes the comprehension of the disease and 
its treatment, cognitive functioning such as the capacity 
for judgement, thinking or memory as well as executive 
function like the capacity to plan.38 Physical capability 
involves the capacity to adapt to lifestyle changes such as 
Figure 1 Key elements of the MRC framework for developing complex interventions.38 MRC, Medical Research Council.
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a diet or social behaviours as well as dexterity.38 ‘Oppor-
tunity’ is subdivided into physical opportunity (provided 
by the environment) and social opportunity (provided by 
the cultural milieu that dictates the way we think about 
things).23 Physical opportunity includes cost, access (eg, 
availability of a weighing scale), regimen complexity, 
social support as well as healthcare professional–patient 
relationship and communication.38 Social opportunity 
comprises the stigma of the disease, the fear of disclosure 
as well as religious and/or cultural beliefs.38 ‘Motivation’ 
is subdivided into reflective processes (involving plans and 
evaluations) and automatic processes (involving emotions 
and impulses that arise from associative learning and/or 
innate dispositions).23 Reflective motivation entails the 
perception of the illness (eg, cause, chronic vs acute), 
beliefs about treatment (eg, necessity, efficacy, concerns 
Figure 2 Application of the COM-B model to self-care adherence.42 COM-B, Capability, Opportunity, Motivation and 
Behaviour. 
Figure 3 The behaviour change wheel.23 30
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about current or future adverse events), outcome expec-
tancies as well as self-efficacy.38 Automatic motivation 
contains stimuli or cues for action as well as mood state 
or mood disorder such as depression and anxiety.38 At the 
end of stage 2, all factors (target behaviours) are mapped 
onto the COM-B model in order to identify behaviour 
change techniques appropriate for modifying behaviours 
(see stage 3 below).
Stage 3: mapping of target behaviours onto behaviour change 
techniques
In the next step, we will identify behaviour change tech-
niques that are appropriate for changing undesirable 
behaviours associated with self-care non-adherence or 
to reinforce desirable behaviours associated with self-
care adherence using the behaviour change wheel 
(figure 3). The middle circle of the ‘behaviour change 
wheel’ contains a choice of nine evidence-based inter-
vention functions that are aimed at addressing the 
target behaviours identified with the help of the COM-B 
model in stage 2. Please note that the outer circle of the 
wheel represents policy categories that will apply less to 
behavioural change in the individual.
In order to develop approaches for change, 
the Taxonomy of Behaviour Change Techniques 
(BCTs) developed by Michie et al36 44 or the concepts 
described by Bartholomew et al41 will be used to allow 
effective mapping of factors onto behaviour change 
techniques to address specific behavioural determinants. 
According to Michie,46 a BCT is defined as
an active component of an intervention designed to 
change behaviour. The defining characteristics of a 
BCT are that it is ‘observable, replicable, irreducible’, 
a component of an intervention designed to change 
behaviour and a postulated active ingredient within 
the intervention. It is thus the smallest component 
compatible with retaining the postulated active ingre-
dients, that is, the proposed mechanisms of change, 
and can be used alone or in combination with other 
BCTs. (p. 182)
The Taxonomy of BCTs was developed in a series of 
consensus exercises involving over 50 behaviour change 
experts from various disciplines and countries. It contains 
93 itemised health BCTs that are clustered into 16 group-
ings; each group containing between 3 and 11 reliable, 
distinct BCTs. This cross-domain taxonomy applies to a 
wide range of behaviours and various types of interven-
tions and enjoys international acceptance and use. We will 
use this taxonomy for the systematic specification of BCIs. 
For example, if a patient has difficulties interpreting his 
or her symptoms or attributes them to existing comor-
bidities, medication side effects or emotional responses, 
then a technique that targets to change psychological 
capability should be selected. A respective intervention 
might involve techniques such as shaping knowledge or 
feedback and monitoring.36 The full range of all BCTs 
available is depicted by Michie et al36 including examples 
of how BCTs can be implemented and information on 
how to operationalise BCTs. At the end of stage 3, BCTs 
are formulated in order to identify relevant factors that 
allow its successful implementation into routine clinical 
work (see stage 4 below).
Stage 4: identifying wider factors that influence successful 
implementation of BCIs into practice
This stage involves the consultation of intended partic-
ipants and implementers to identify wider relevant 
factors needed for successful implementation of BCIs 
into routine work. Suggested BCIs will be translated into 
locally relevant interventions using the Normalisation 
Process Theory (NPT) to overcome the difficulties of 
implementing theoretically derived interventions into 
everyday practice.47 48 NPT will be used to identify factors 
that individuals and groups need to do in order to enable 
true integration of BCIs designed in stage 3 into routine 
work.49 To promote adoption and faithful delivery of our 
interventions in the future, it is crucial to involve all stake-
holders in determining the intervention content and the 
best way to deliver it.50 NPT will provide guiding ques-
tions for qualitative interviews with key stakeholders that 
will shed light on a range of relevant contextual issues48 
necessary to increase practical effectiveness, that is, 
whether the intervention will work in clinical practice.51 
Consequently, NPT assists in better defining the core 
components of the intervention and to examine accept-
ability to patients, their families and health professionals.
Qualitative semistructured interviews with approxi-
mately 15–17 key stakeholders, that is, those targeted 
by the intervention or involved in its development 
or delivery, will be conducted using NPT to guide the 
interview questions. Potential participants (eg, patients 
with HF, health professionals, academics and so on) will 
be identified by the participatory planning group (see 
above) to ensure that all relevant stakeholders are repre-
sented and their views and preferences are sought. Partic-
ipants will be contacted by the researcher to arrange for 
the interview. Interviews will be conducted in places that 
are convenient for the stakeholders according to their 
preferences. As described by Lovell et al,52 guiding inter-
view questions will cover the four components of NPT, 
that is, (1) questions considering meaning and sense 
making by stakeholders (coherence); (2) commitment 
and engagement by stakeholders (cognitive participa-
tion); (3) the work stakeholders do to make the inter-
vention function (collective action) and (4) stakeholders 
appraising the intervention (reflexive monitoring). In 
addition, interviews will allow reflection on, and refine-
ment of, content and acceptability of BCTs as well as 
specific information regarding the following eight 
descriptors suggested for the standardised description 
of BCIs: (1) content or elements of the intervention; 
(2) characteristics of self-care tutors (eg, health profes-
sionals,  lay tutors); (3) characteristics of the target popu-
lation (eg, adults,  children); (4) delivery location (eg, 
hospital, GP practice,  home environment); (5) mode 
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of delivery (eg, group-based,  individual approach); (6) 
format (eg, lectures,  manual); (7) intensity (eg, contact 
time) and (8) duration (eg, number of sessions over a 
given period).53
Participating key stakeholders will be asked for consent 
to the interview. All interviews will be audio recorded 
and transcribed verbatim; specific details will be anony-
mised. Qualitative data will be analysed using thematic 
analysis.54 To assure validity, interview texts will be anal-
ysed in a multidisciplinary team by reading the transcripts 
and identifying emerging themes and categories. Anal-
ysis of the data will be informed by the aforementioned 
four components of the NPT framework. Regarding 
the eight descriptors, in addition to obtaining informa-
tion from our stakeholders through qualitative enquiry, 
we will also retrieve and summarise, if available, specific 
HF self-care-related evidence from previously published 
quantitative reviews. For example, is there any evidence 
that supports the effectiveness of either group-based or 
individual approaches (mode of delivery) in enhancing 
self-care in patients with HF? The results of the reviews, if 
any, will be combined with the individual responses from 
the key stakeholders on a matrix; any ambiguities will 
be addressed with the help of a consensus development 
method (Delphi technique) in order to achieve clarity 
concerning the descriptors.
Finally, the Delphi technique—a formal consensus 
development research method—involving all key stake-
holders will be used to elicit consensus. All stakeholders 
will receive an invitation to participate, detailing the 
rationale for the consensus exercise. A matrix of the 
combined results and a copy of the Delphi questionnaire 
will be circulated. Stakeholders who will not respond 
within 4 weeks will receive a follow-up invitation. The 
matrix will serve as a platform for discussion to derive 
the final intervention manual. The Delphi questionnaire 
will deal specifically with the mixed responses (ambigu-
ities) that remain regarding the descriptors. The process 
of collating and distributing an anonymised summary of 
the stakeholders’ responses and adjusting earlier answers 
based on feedback from the group will be repeated for 
a maximum of three rounds. In line with the recom-
mendations by Diamond et al,55 consensus will be a priori 
operationalised as a proportion of participants agreeing 
to a particular descriptor. For example, the threshold for 
determination of consensus might be set at 75% of partic-
ipating stakeholders.56 If, however, consensus values for 
certain descriptors will remain below the prespecified 
threshold after the third iteration, a rank order will be 
used instead giving preference to the descriptor with the 
highest degree of agreement. In summary, the Delphi 
technique will aid in fine-tuning our BCIs to increase the 
likelihood of its acceptance. At the end of stage 4, we will 
have produced a final version of the intervention manual 
containing well-defined theory-based BCIs including the 
concept and outline of an exploratory trial ready for pilot 
testing in a subsequent full randomised controlled inter-
vention trial.
dIsCussIon
The main outcome of this study is to produce a detailed 
intervention manual that contains well-defined (ie, using 
the eight descriptors suggested for the standardised 
description of interventions) theory-based (ie, based 
on the COM-B behaviour model) BCIs. Following the 
MRC framework for designing complex interventions, 
the envisaged subsequent studies encompass: (1) the 
execution of an exploratory trial, and if feasible, (2) the 
completion of a full RCT. Within the scope of an explor-
atory trial, the feasibility and acceptance of the actual 
intervention described in the manual will be pilot tested. 
Particular emphasis will be placed on recruitment strat-
egies, estimates of recruitment numbers, collaborating 
institutions or issues concerning the identification of 
specific outcome measures for a full RCT. Finally, an 
economic evaluation in the form of a cost-effectiveness 
analysis will be conducted as part of evaluating the BCIs 
compared with an appropriate alternative. Therefore, the 
design of a health economic evaluation (eg, cost-effective-
ness analysis, cost-utility analysis) from both a societal and 
a statutory health insurance perspective will be developed 
and appropriate measures for effects and costs defined as 
well as instruments for data collection.
strengths and limitations of this study
All BCIs are based on a sound theoretical framework. 
Besides that, continuous consultation with potential key 
stakeholders, that is, end users and healthcare providers, 
will inform intervention development to ensure successful 
implementation of BCIs into practice. Furthermore, the 
final intervention manual will contain specific informa-
tion regarding the eight descriptors suggested for the 
standardised description of BCIs to allow for replica-
tion. However, the execution of a full RCT design is not 
possible within the study budget and time frame, but this 
current study will collect important data to inform a full-
scale RCT in the future.
Ethics and dissemination
The findings of the study will be disseminated through 
peer-reviewed journal articles, national and interna-
tional conference presentations and stakeholder engage-
ment activities (ie, via our participatory planning group 
members).
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